Fortis Healthcare Ltd., Blue Star Ltd., and 360 ONE WAM Ltd. are among the Indian companies added to the FTSE All-World Index, according to the FTSE India March 2025 semi-annual review that was announced on Friday, which will take effect from March 21 and is expected to generate significant trading flows.
Other additions to the index include Ajanta Pharma Ltd., Apar Industries Ltd., Bajaj Housing Finance Ltd., BSE Ltd., Central Depository Services (India) Ltd., Crisil Ltd., Fertilisers and Chemicals Travancore Ltd., IndusInd Bank Ltd., Kaynes Technology India Ltd., National Aluminium Company Ltd., and Premier Energies Ltd.
Also Read: MSCI Rejig: Hyundai India Only Addition In February Review; IndusInd Bank, Zomato Weights To Rise
The FTSE All-World Index is a market capitalisation-weighted index that tracks the performance of large and mid-cap stocks from the FTSE Global Equity Index Series. It includes companies from both developed and emerging markets, making it a key benchmark for global investors. The index helps fund managers, institutional investors, and analysts assess market performance and allocate capital efficiently. As of 31 January, 245 Indian companies are part of the index.
India has gained prominence in global indices as its economy expands and market capitalisation grows. As more Indian companies get included, foreign institutional investment tends to increase, boosting liquidity and participation in the Indian stock market. The country’s increasing weight in international benchmarks has attracted foreign institutional investors, leading to higher liquidity and broader participation in Indian equities.
According to IIFL Capital (Alt Desk) projections, 360 ONE WAM, Blue Star, and Fortis Healthcare could see estimated inflows of $49 million, $54 million, and $65 million, respectively. These inflows represent significant multiples of their average daily volume.